•  
  •  
 

Document Type

Original Article

Abstract

Background Hepato-cellular carcinoma is the fifth most common neoplasm in the world and the third most common cause of cancer death worldwide. HCC is responsible for more than one million deaths annually worldwide, representing 10% of all deaths from cancer. Objective To determine the different survival rates of HCC after different modalities of management: Radio-Frequency Ablation (RFA), Trans Arterial Chemo Embolization (TACE), Liver Resection and Living Donor Liver Transplantation (LDLT). Patients and Methods This study was conducted on fifty patients having hepatocellular carcinoma during the period from March 2014 to May 2017. They were classified according to their ages into 3 groups, the first one included 8 patients above 60 year (16%), 38 patients between 50 and 60 years (76%) in the second group, and 4 patients (8%) below 50 years in the last group. Results:

Of the 50 treated patients, 20 HCC nodules were treated in 20 sessions, 10 patients were with a single session, and 5 patients with two sessions. In these ten patients who subjected to RFA was apparent. This response continued with follow up, as patients mass and AFP level decreased with time. In patients who did not respond well, we did the second ablation. Four of those five patients, showed improvement and eighteen sessions of TACE were done for these ten patients. Two patients had taken two sessions, while three patients received three sessions. Five patients received only one session as there was no improvement after the session diagnosed by CT.

Keywords

Hepatocellular Carcinoma; radio frequency ablation

Subject Area

General Surgery

Download

Share

COinS